Novel Insights into Stem Cell and Bio-Markers Conference

Oct 09-10, 2019

Abudhabi, United Arab Emirates

Conference on Stem Cells and BioMarkers in 2019 in Abudhabi, UAE

Lexis is the world best platform for all the researchers to showcase their on-going research work through Oral/Poster presentations in front of the international audience, provided with additional opportunities for expanding their research work by conducting workshops and by exhibiting products.Stem Cells and BioMarkers Conference famously known as Stem Cell 2019 Abu Dhabi.

It gives you the global exposure and helps to associate with the present and potential researchers who discover novel techniques through stem cells and biomarkers with different approach. This meet enlightens the latest treatment advancements in Stem cell biomarkers research around the globe who concentrates on growth about ongoing advances like first stage analysis to treatment etc. This is the best chance to achieve the biggest array of members.

This conference invites Cell biology and Stem cell researchers, Oncologists, Academicians, Physicians, Academic scientists, Radiologists, Chemo therapists, Industry professionals, Head of the departments, Directors, Clinical Professionals, Young researchers, Postgraduates, Trainees and all stem cell biomarkers Researchers. It also gives the best opportunity to the Business professionals to represent their company.

Stem Cells 2019 Abu Dhabi cordially conducted by the Lexis in Abu Dhabi, UAE on Oct 09-10, 2019 mainly focuses on cause and cure for genetic disorders and treatment through the regenerative medicine . The congress runs with the theme “Building Blocks of Life - Breaking the Barriers through Stem Cell Research and Biomarker”.

Ten years in public health

"Report by Dr.Margaret Chan, Director-General, World Health Organization"

Ten years in public health "2007-2017" chronicles the evolution of global public health during the tenure of Dr Chan, WHO Director-General. This series of chapters evaluates successes, setbacks, and enduring challenges during her administration. They show what needs to be done when progress stalls or new threats emerge. The chapters (links are below) show how WHO technical leadership can get multiple partners working together in tandem under coherent strategies. The importance of country leadership and community engagement is stressed repeatedly throughout the chapters. (Source WHO)

Details of Stem Cell and Biomarkers Conference 2018:

Conference Name Place Date
Stem Cell 2019 Abu Dhabi Abudhabi, UAE October 9-10, 2019


Stem Cell Conferences | Lexis Conferences | Abu Dhabi | UAE | Conference | Lexis Middle East Conferences

The worldwide stem cell market expected is required to enlist a CAGR of 15% amid the estimated time of 2018– 2023. stem cells are unspecialized cells, which have a surprising property of forming into various types of cell composes, amid their initial life and development period inside the human body. When they isolate, every cell can possibly remain either the same or change into a particular cell compose. Along these lines, under certain physiologic or trial conditions, these cells can be instigated to end up tissue-particular or organ-particular with unique capacities.


Based on type, the worldwide undifferentiated organism treatment showcase is separated into two noteworthy classifications, to be specific, allogeneic foundational microorganism treatment and autologous undeveloped cell treatment. The allogeneic foundational microorganism treatment portion is required to order the biggest offer in the worldwide undifferentiated organism treatment showcase in 2016. This expansive offer can principally be ascribed to the rising commercialization of allogeneic immature microorganism treatment items, more extensive restorative utilizations of allogeneic undifferentiated organisms, simple generation scale-up process, and developing number of clinical preliminaries identified with allogeneic undeveloped cell treatments.

The Global Stem Cell Market In Million's


Stem Cells and Bio-Markers Conference famously known as Stem Cell 2019 Abu Dhabi.


Nefize Sertac Kip
Sema4, USA



She is a pathologist who has completed her training at Mayo Clinic, Rochester MN five years ago. She has triple boarded for anatomic, clinical and molecular genetics pathology. She is currently working as the Director of Oncology at Sema4 Genomics Laborat

Bhuvarahamurthy V
University of Madras

Rui Damazio Alvites
University Do Porto


Researches :

  • Mesenchymal Stem Cells, Olfactory Mucosa Mesenchymal Stem Cells, Biomaterials, Peripheral Nerve Injury and Regeneration, Veterinary Medicine, Translational Medicine, One Health

Program Overview